PT-141 costs between $80 to $200 per injection at most telehealth clinics in 2026, with monthly treatment packages ranging from $300 to $800 depending on dosing frequency and provider. Compounded versions typically cost 40-60% less than FDA-approved Vyleesi brand bremelanotide, which runs approximately $900 per month without insurance coverage. Most patients use PT-141 2-3 times per week for optimal results, making the average monthly cost $480-1,200 for compounded versions. Insurance rarely covers PT-141 for sexual health applications, though some HSA and FSA accounts accept these expenses. Telehealth providers often offer subscription models with discounts for longer commitments, bringing per-injection costs down to $60-120 range. The peptide requires subcutaneous injection and shows effectiveness in clinical trials within 45 minutes of administration for both men and women with sexual dysfunction.
Key Takeaways
- PT-141 injections cost $80-200 each at telehealth clinics, with monthly packages from $300-800
- Compounded bremelanotide costs 40-60% less than FDA-approved Vyleesi brand medication
- Insurance coverage is rare, but HSA/FSA funds may be eligible for sexual health treatments
- Subscription models and bulk purchasing can reduce per-injection costs significantly
- Clinical effectiveness appears within 45 minutes, lasting 6-24 hours per dose
Compounded PT-141 Pricing Breakdown
Compounded PT-141 from licensed pharmacies costs significantly less than brand-name options while maintaining clinical efficacy. Most telehealth providers source their bremelanotide from 503B compounding facilities, which can legally manufacture peptides for individual patient prescriptions. A typical 2mg vial costs $120-180 and contains 4-8 doses depending on your prescribed strength. The standard starting dose ranges from 0.75mg to 1.75mg per injection, administered subcutaneously in the abdomen or thigh. At 1mg per dose, a single vial provides approximately 8 treatments, bringing the per-injection cost to $15-22.50. However, clinic markup and consultation fees typically bring the total per-treatment cost to the $80-200 range mentioned earlier. Many providers offer tiered pricing based on commitment length. A three-month supply might cost $900-1,500, while six-month packages can reduce costs by 15-25%. Some clinics include injection supplies, alcohol swabs, and shipping in their package prices, while others charge separately for these items.Brand Name Vyleesi Costs and Insurance Coverage
FDA-approved Vyleesi carries a list price of approximately $900 per month for the standard dosing regimen. This brand-name bremelanotide comes pre-loaded in autoinjector pens, making administration more convenient but significantly more expensive. Each pen contains a single 1.75mg dose, which is the only strength available for the commercial product. Insurance coverage for Vyleesi remains limited in 2026, with most plans considering it an elective or lifestyle medication rather than medically necessary treatment. Some insurance providers may cover the medication if you have documented hypoactive sexual desire disorder (HSDD) and have failed other treatments, but prior authorization requirements are stringent. Without insurance, patient assistance programs from the manufacturer can reduce costs for qualifying individuals. However, income limits and other restrictions often exclude middle-income patients who find the medication financially challenging but don't qualify for assistance programs.Telehealth Provider Pricing Models
Different telehealth platforms structure their PT-141 pricing in various ways, affecting your total monthly costs. Subscription-based models typically offer the best value for regular users, with monthly fees ranging from $299 to $599 that include consultations, medication, and supplies. Pay-per-dose models allow more flexibility but usually cost more per injection. These typically range from $89 to $179 per dose, plus consultation fees of $50-150 for initial evaluations. Follow-up consultations might be included or charged separately at $25-75 per session. Some providers bundle PT-141 with other peptide therapy options, creating complete sexual health packages. These combinations might include testosterone replacement therapy consultations, nutritional guidance, or other supportive treatments at discounted rates compared to purchasing services individually.Dosing Frequency Impact on Monthly Costs
Your prescribed dosing schedule directly affects monthly PT-141 expenses. Clinical studies show effectiveness with administration 2-8 hours before anticipated sexual activity, but frequency varies significantly between patients. Some individuals use the peptide 2-3 times weekly, while others need it only occasionally. For patients using PT-141 twice weekly at $100 per injection, monthly costs reach approximately $800. Those requiring it three times weekly face costs around $1,200 monthly. However, many patients find they can reduce frequency over time as their sexual function improves, leading to lower long-term costs. Starting with a conservative dosing schedule helps manage both costs and side effects while determining your optimal treatment frequency. Most providers recommend beginning with once-weekly dosing and adjusting based on response and tolerance.Comparing Costs to Other Sexual Health Treatments
PT-141 pricing falls within a similar range to other peptide-based sexual health treatments but offers unique benefits for both men and women. Traditional erectile dysfunction medications like Viagra cost $15-70 per dose depending on strength and source, but these only address male sexual function and require different timing considerations. Testosterone replacement therapy costs vary widely, from $30-200 monthly for gels to $200-500 for injection protocols. However, testosterone therapy requires ongoing monitoring with blood tests, adding $100-300 in laboratory costs every 3-6 months. Sermorelin and other growth hormone-releasing peptides cost $200-400 monthly and may indirectly support sexual function through improved energy and body composition, but lack the direct mechanism of action that PT-141 provides for sexual arousal.Insurance and HSA/FSA Considerations
Most health insurance plans classify PT-141 as an elective treatment, similar to cosmetic procedures, making coverage unlikely. However, documentation of hypoactive sexual desire disorder or other recognized sexual dysfunction conditions may improve approval chances for some patients. Health Savings Account (HSA) and Flexible Spending Account (FSA) eligibility varies by plan administrator and requires a prescription for a diagnosed medical condition. Many patients successfully use these pre-tax funds for PT-141 treatments, effectively reducing costs by 20-30% depending on their tax bracket. Some employers offer supplemental benefits that cover sexual health treatments, particularly for female employees dealing with HSDD. These benefits are becoming more common as companies recognize the impact of sexual health on overall wellness and quality of life.Cost-Saving Strategies for PT-141 Treatment
Several approaches can help reduce your PT-141 treatment costs without compromising quality or safety. Choosing providers that offer package deals or subscription models typically provides better value than pay-per-dose arrangements, especially for patients planning long-term treatment. Combining PT-141 with other peptide treatments through the same provider often unlocks volume discounts. Some patients coordinate their treatment with BPC-157 or TB-500 protocols, sharing shipping costs and benefiting from bulk pricing structures. Timing your purchases around promotional periods can yield significant savings. Many telehealth providers offer discounts during specific months or for new patient enrollments. However, ensure you're working with licensed providers and verified compounding pharmacies regardless of pricing incentives.Frequently Asked Questions
How much does a typical PT-141 injection cost?
PT-141 injections typically cost between $80-200 each through telehealth providers in 2026. This price usually includes the medication, consultation fee, and injection supplies. Compounded versions cost significantly less than FDA-approved Vyleesi, which runs about $900 monthly. Package deals and subscription models can reduce per-injection costs to $60-120 range.
See transparent compounded pricing
Review compounded medication pricing and what provider-reviewed care includes, with no surprises at checkout.
Try the Cost Calculator →View data table
| Category | Relative Cost Index | Detail |
|---|---|---|
| Brand Ozempic | 95 | $900-1,350/mo without insurance |
| Brand Wegovy | 90 | $1,300-1,600/mo without insurance |
| Brand Mounjaro | 88 | $1,000-1,200/mo without insurance |
| Compounded | 25 | $299-449/mo at FormBlends |
Does insurance cover PT-141 treatments?
Insurance rarely covers PT-141 for sexual health applications, as most plans consider it elective treatment. Some coverage may be possible with documented hypoactive sexual desire disorder and prior authorization, but approval rates remain low. HSA and FSA funds may be eligible with a valid prescription for diagnosed sexual dysfunction conditions.
What's the difference between compounded PT-141 and Vyleesi pricing?
Compounded PT-141 costs 40-60% less than brand-name Vyleesi, which has a list price around $900 monthly. Compounded versions from 503B pharmacies typically cost $300-800 monthly depending on dosing frequency. Both contain the same active ingredient (bremelanotide) but differ in preparation, packaging, and regulatory approval status.
Can I reduce PT-141 costs with bulk purchasing?
Yes, many providers offer volume discounts for 3-6 month supplies, reducing costs by 15-25%. Subscription models typically provide better per-dose pricing than pay-per-injection options. Some telehealth platforms also offer loyalty programs or referral discounts that can further reduce treatment costs over time.
How often do I need PT-141 injections?
PT-141 is typically used 2-8 hours before anticipated sexual activity, not on a daily basis. Most patients use it 2-3 times weekly, though frequency varies based on individual needs and response. This as-needed dosing schedule affects monthly costs significantly, ranging from $200-1,200 depending on usage patterns.
Are there additional costs beyond the medication?
Additional costs may include initial consultation fees ($50-150), follow-up appointments ($25-75), injection supplies if not included, and shipping charges. Some providers bundle these costs into package pricing, while others charge separately. Laboratory monitoring is generally not required for PT-141 treatment.
What payment options do PT-141 providers accept?
Most telehealth providers accept credit cards, debit cards, HSA/FSA cards, and some offer financing options or payment plans. Cash payments are less common due to the prescription nature of the medication. Some platforms offer auto-pay discounts for subscription models, and cryptocurrency payments are increasingly accepted by select providers.
How do PT-141 costs compare to other sexual health treatments?
PT-141 costs are comparable to other specialty sexual health treatments. Traditional ED medications cost $15-70 per dose but only work for men. Testosterone therapy ranges from $30-500 monthly plus monitoring costs. PT-141 offers unique benefits for both men and women with sexual dysfunction, making cost comparisons dependent on individual treatment needs.
Sources
- Kingsberg SA, Clayton AH, Portman D, et al. Bremelanotide for the treatment of hypoactive sexual desire disorder: two randomized phase 3 trials. Obstet Gynecol. 2019;134(5):899-908. PMID: 31599839
- Clayton AH, Kingsberg SA, Goldstein I, et al. Evaluation of flibanserin: science and advocacy at the FDA. J Sex Med. 2016;13(8):1210-1216. PMID: 27436074
- Diamond LE, Earle DC, Rosen RC, et al. Double-blind, placebo-controlled evaluation of the safety, pharmacokinetic properties and pharmacodynamic effects of intranasal PT-141. Int J Impot Res. 2006;18(6):556-567. PMID: 16775601
- Safarinejad MR. Evaluation of the safety and efficacy of bremelanotide, a melanocortin receptor agonist, in female subjects with arousal disorder: a double-blind placebo-controlled, fixed dose, randomized study. J Sex Med. 2008;5(4):887-897. PMID: 18194184
- Rosen RC, Diamond LE, Earle DC, et al. Evaluation of the safety, pharmacokinetics and pharmacodynamic effects of subcutaneously administered PT-141 in healthy male subjects and in patients with mild-to-moderate erectile dysfunction. Int J Impot Res. 2004;16(2):135-142. PMID: 14961047
- Food and Drug Administration. FDA approves new treatment for hypoactive sexual desire disorder in premenopausal women. FDA News Release. June 21, 2019.
- Kingsberg SA, Portman DJ. Sexual function and satisfaction with bremelanotide treatment in women with hypoactive sexual desire disorder. Sex Med. 2019;7(4):466-474. PMID: 31494402
See your options in about 2 minutes
Take the free quiz and see what fits you. Quick, private, and no commitment to continue.
See my options →